HER2-targeted CAR T cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HER2-targeted CAR T cells, covering 2025-07-15 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma [Phase 1]